3-5
2026
影响因子区间
77天
平台估算
14%
2025
中国作者发文占比
3150 CHF
收费
期刊简介:Diabetes Therapy is an international, peer reviewed, rapid-publication (peer review in 2 weeks, published 3–4 weeks from acceptance) journal dedicated to the publication of high-quality clinical (all phases), observational, real-world, and health outcomes research around the discovery, development, and use of therapeutics and interventions (including devices) across all areas of diabetes. Studies relating to diagnostics and diagnosis, pharmacoeconomics, public health, epidemiology, quality of life, and patient care, management, and education are also encouraged.The journal is of interest to a broad audience of healthcare professionals and publishes original research, reviews, communications and letters. The journal is read by a global audience and receives submissions from all over the world. Diabetes Therapy will consider all scientifically sound research be it positive, confirmatory or negative data. Submissions are welcomed whether they relate to an international and/or a country-specific audience, something that is crucially important when researchers are trying to target more specific patient populations. This inclusive approach allows the journal to assist in the dissemination of all scientifically and ethically sound research.
【译文】糖尿病治疗是一个国际性的、同行评审的、快速发表的(同行评审2周,接受后3-4周出版)期刊,致力于发表关于糖尿病治疗(包括设备)的发现、开发和使用的临床(所有阶段)、观察性、现实世界和健康结果研究的高质量临床研究。与诊断和诊断、药物经济学、公共卫生、流行病学、生活质量以及患者护理、管理和教育相关的研究也受到鼓励。该期刊对广泛的医疗保健专业人员感兴趣,并发表原创研究、评论、通讯和信件。该期刊被全球读者阅读,并接受来自世界各地的投稿。糖尿病治疗将考虑所有科学上可靠的研究,无论是积极、证实还是负面数据。无论它们是否与国际和/或特定国家受众相关,这对于研究人员试图针对更具体的患者群体至关重要。这种包容性方法使该期刊能够帮助传播所有科学和伦理上可靠的研究。

| 指标 | 当前值 | 近三年趋势 |
|---|---|---|
| JCR分区 | Q2 | 暂无 |
| 中科院分区 | 3区 | 暂无 |
| 影响因子区间 | 3-5 | 暂无 |